US5888534A
(en)
*
|
1995-06-13 |
1999-03-30 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
GB9700878D0
(en)
*
|
1997-01-17 |
1997-03-05 |
Scherer Ltd R P |
Dosage forms and method for ameliorating male erectile dysfunction
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
IN186245B
(da)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US5945117A
(en)
*
|
1998-01-30 |
1999-08-31 |
Pentech Pharmaceuticals, Inc. |
Treatment of female sexual dysfunction
|
US6495539B1
(en)
|
1998-02-19 |
2002-12-17 |
Washington University |
B-lactam-like chaperone inhibitors
|
GT199900061A
(es)
*
|
1998-05-15 |
2000-10-14 |
Pfizer |
Formulaciones farmaceuticas.
|
US6011035A
(en)
|
1998-06-30 |
2000-01-04 |
Neuromed Technologies Inc. |
Calcium channel blockers
|
US20020169145A1
(en)
*
|
1998-10-14 |
2002-11-14 |
Rajen Shah |
Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
|
US6291471B1
(en)
*
|
1998-12-17 |
2001-09-18 |
Abb Holdings, Inc. |
Use of apomorphine for the treatment of organic erectile dysfunction in males
|
WO2000054777A1
(en)
*
|
1999-03-16 |
2000-09-21 |
Pentech Pharmaceuticals, Inc. |
Controlled release of sildenafil delivered by sublingual or buccal administration
|
AU762934B2
(en)
|
1999-09-03 |
2003-07-10 |
Allergan Sales, Llc |
Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
|
US6841559B1
(en)
|
1999-11-19 |
2005-01-11 |
Washington University Of St. Louis |
Pyridinones to treat and prevent bacterial infections
|
CZ20023637A3
(cs)
|
2000-04-07 |
2003-02-12 |
Tap Pharmaceutical Products, Inc. |
Deriváty apomorfinu a způsoby jejich použití
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
WO2002062315A1
(en)
*
|
2001-02-08 |
2002-08-15 |
Pharmacia Corporation |
Rapid-onset medicament for the treatment of sexual dysfunction
|
US20060127474A1
(en)
*
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
US20110033542A1
(en)
*
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
CN100346832C
(zh)
*
|
2002-02-07 |
2007-11-07 |
法玛西雅公司 |
经粘膜递送的药物剂型
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
GB0221711D0
(en)
*
|
2002-09-19 |
2002-10-30 |
Ardana Bioscience Ltd |
Methods
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7507760B2
(en)
*
|
2004-01-22 |
2009-03-24 |
Neuromed Pharmaceuticals Ltd. |
N-type calcium channel blockers
|
WO2005102330A2
(en)
*
|
2004-04-16 |
2005-11-03 |
Washingtion University |
Amino methylated 2-pyridinones
|
US20080064602A1
(en)
*
|
2004-09-09 |
2008-03-13 |
Ernest Schay |
Pharmaceutical Composition
|
US20070020186A1
(en)
|
2005-07-22 |
2007-01-25 |
Alpex Pharma S.A. |
Solid dosage formulations of narcotic drugs having improved buccal adsorption
|
JP2009504803A
(ja)
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Tlrアゴニスト
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
US20090286806A1
(en)
*
|
2006-04-17 |
2009-11-19 |
Hassan Pajouhesh |
Isoxazole derivatives as calcium channel blockers
|
WO2007142755A2
(en)
|
2006-05-31 |
2007-12-13 |
The Regents Of The University Of California |
Purine analogs
|
AU2007289065B2
(en)
|
2006-09-01 |
2013-03-14 |
Senhwa Biosciences, Inc. |
Serine-threonine protein kinase and PARP modulators
|
US20100168103A1
(en)
*
|
2006-09-14 |
2010-07-01 |
Neuromed Pharmaceuticals Ltd. |
Diaryl piperidine compounds as calcium channel blockers
|
CA2666275A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Neuromed Pharmaceuticals Ltd. |
Cyclopropyl-piperazine compounds as calcium channel blockers
|
US20090054333A1
(en)
*
|
2006-10-17 |
2009-02-26 |
Antonio Giordano |
Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
|
CN101790380B
(zh)
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
JP5454943B2
(ja)
*
|
2007-04-12 |
2014-03-26 |
ジョイアント ファーマスーティカルズ、インク. |
抗癌剤として有用なsmac模倣二量体及び三量体
|
WO2009002838A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Cylene Pharmaceuticals, Inc. |
Methods for treating ophthalmic disorders
|
WO2009002870A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Cylene Pharmaceuticals, Inc. |
Methods for treating aberrant cell proliferation disorders
|
US7910600B2
(en)
*
|
2007-08-31 |
2011-03-22 |
Cylene Pharmaceuticals, Inc. |
Therapeutic kinase modulators
|
US8486928B2
(en)
|
2007-11-14 |
2013-07-16 |
Galera Therapeutics |
Super-oxide dismutase mimetics
|
US20090155392A1
(en)
*
|
2007-12-17 |
2009-06-18 |
Bret David Nelson |
Methods and Systems for Sublingual Guarana Administration
|
WO2009086170A1
(en)
*
|
2007-12-21 |
2009-07-09 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs with improved solubility
|
WO2009099650A2
(en)
*
|
2008-02-07 |
2009-08-13 |
Carson Dennis A |
Treatment of bladder diseases with a tlr7 activator
|
EP2259678A4
(en)
*
|
2008-02-29 |
2011-07-27 |
Cylene Pharmaceuticals Inc |
PROTEIN KINASE MODULATORS
|
WO2009132453A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Neuromed Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
CA2722706A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Zalicus Pharmaceuticals Ltd. |
Di-t-butylphenyl piperazines as calcium channel blockers
|
WO2009132452A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Neuromed Pharmaceuticals Ltd. |
Diaryl-cyclylalkyl derivatives as calcium channel blockers
|
JP5123429B2
(ja)
*
|
2008-04-29 |
2013-01-23 |
ジョイアント ファーマスーティカルズ、インク. |
インドリン抗癌剤
|
US8153619B2
(en)
*
|
2008-05-22 |
2012-04-10 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs
|
US8377968B2
(en)
|
2008-06-02 |
2013-02-19 |
Zalicus Pharmaceuticals, Ltd. |
N-piperidinyl acetamide derivatives as calcium channel blockers
|
US9241896B2
(en)
|
2008-12-19 |
2016-01-26 |
Ultragenyx Pharmaceutical Inc. |
Methods and formulations for treating sialic acid deficiencies
|
US20130213393A1
(en)
|
2009-12-22 |
2013-08-22 |
Evoke Pharma, Inc. |
Nasal formulations of metoclopramide
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
BRPI1008383A2
(pt)
|
2009-02-11 |
2016-02-23 |
Univ California |
composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
|
EP2442650B1
(en)
|
2009-06-12 |
2015-08-26 |
Cynapsus Therapeutics Inc. |
Sublingual apomorphine
|
BR112012004304A2
(pt)
|
2009-08-26 |
2016-03-15 |
Cylene Pharmaceuticals Inc |
quinolinas condensadas como moduladores de proteína cinase.
|
WO2011059763A2
(en)
|
2009-10-28 |
2011-05-19 |
Joyant Pharmaceuticals, Inc. |
Dimeric smac mimetics
|
CA2782056C
(en)
|
2009-11-25 |
2021-03-09 |
Arisgen Sa |
Mucosal delivery of peptides
|
RU2607453C2
(ru)
|
2009-12-04 |
2017-01-10 |
Сенхва Байосайенсиз, Инк. |
Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы
|
WO2011134669A1
(en)
|
2010-04-30 |
2011-11-03 |
Telormedix Sa |
Methods for inducing an immune response
|
US9050319B2
(en)
|
2010-04-30 |
2015-06-09 |
Telormedix, Sa |
Phospholipid drug analogs
|
NZ603155A
(en)
|
2010-04-30 |
2014-06-27 |
Telormedix Sa |
Phospholipid drug analogs
|
CA2805222A1
(en)
|
2010-07-13 |
2012-01-19 |
Ultragenyx Pharmaceutical Inc. |
Methods and formulations for treating sialic acid deficiencies
|
WO2012038058A1
(en)
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|
EP2630132A1
(en)
|
2010-10-22 |
2013-08-28 |
Université de Strasbourg |
Pochoxime conjugates useful for the treatment of hsp90 related pathologies
|
AU2011343429B2
(en)
|
2010-12-16 |
2016-10-20 |
Sunovion Pharmaceuticals Inc. |
Sublingual films
|
WO2012116440A1
(en)
|
2011-03-03 |
2012-09-07 |
Zalicus Pharmaceuticals Ltd. |
Benzimidazole inhibitors of the sodium channel
|
US8591944B2
(en)
*
|
2011-03-08 |
2013-11-26 |
Zalicus Pharmaceuticals Ltd. |
Solid dispersion formulations and methods of use thereof
|
ES2652444T3
(es)
|
2011-04-22 |
2018-02-02 |
Joyant Pharmaceuticals, Inc. |
Análogos de diazonamida
|
WO2013063149A1
(en)
|
2011-10-24 |
2013-05-02 |
Ultragenyx Pharmaceutical, Inc. |
Sialic acid analogs
|
EP2903987B1
(en)
|
2012-10-01 |
2017-09-20 |
Urogen Pharma Ltd. |
Phospholipid drug analogs
|
US20140335139A1
(en)
|
2013-05-13 |
2014-11-13 |
NeuOra Microceuticals, LLC |
Long lasting breath mint
|
MX2016006087A
(es)
|
2013-11-11 |
2016-08-12 |
Impax Laboratories Inc |
Formulaciones de desintegracion rapida y metodos de uso.
|
US9758518B2
(en)
|
2015-03-04 |
2017-09-12 |
Pimera, Inc. |
Compositions, uses and methods for making them
|
CN107278151A
(zh)
|
2014-12-15 |
2017-10-20 |
约翰霍普金斯大学 |
舒尼替尼制剂及其在治疗青光眼中的使用方法
|
TW201629069A
(zh)
|
2015-01-09 |
2016-08-16 |
霍普驅動生物科技股份有限公司 |
參與協同結合之化合物及其用途
|
EP3247378B8
(en)
|
2015-01-09 |
2023-08-23 |
Revolution Medicines, Inc. |
Macrocyclic compounds that participate in cooperative binding and medical uses thereof
|
WO2016172095A1
(en)
|
2015-04-21 |
2016-10-27 |
Cynapsus Therapeutics, Inc. |
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
|
WO2017048817A1
(en)
|
2015-09-14 |
2017-03-23 |
Ultragenyx Pharmaceutical Inc. |
Crystal forms of sialic acid or salt or solvate thereof
|
JP7411326B2
(ja)
|
2015-10-01 |
2024-01-11 |
ワープ ドライブ バイオ インコーポレイテッド |
タンパク質-タンパク質インターフェースを分析するための方法および試薬
|
WO2017083779A1
(en)
|
2015-11-12 |
2017-05-18 |
Graybug Vision, Inc. |
Aggregating microparticles for therapy
|
US20190144503A1
(en)
|
2016-04-27 |
2019-05-16 |
Regents Of The University Of Minnesota |
Methods for the identification of bifunctional compounds
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
WO2018112061A1
(en)
|
2016-12-15 |
2018-06-21 |
Evoke Pharma, Inc. |
Treatment of moderate and severe gastroparesis
|
EP3600324A4
(en)
|
2017-03-23 |
2020-12-09 |
Graybug Vision, Inc. |
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
|
EP3601286A4
(en)
|
2017-03-28 |
2020-09-23 |
Pimera, Inc. |
NEW CRYSTALLINE SHAPES OF A POL1 INHIBITOR
|
CN111201040A
(zh)
|
2017-05-10 |
2020-05-26 |
灰色视觉公司 |
用于医学疗法的缓释微粒及其悬浮液
|
WO2019126344A1
(en)
|
2017-12-20 |
2019-06-27 |
Bellicum Pharmaceuticals, Inc. |
Multimeric piperidine derivatives
|
SG11202100593PA
(en)
*
|
2018-07-27 |
2021-02-25 |
Serina Therapeutics Inc |
Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same
|
TW202116314A
(zh)
|
2019-07-11 |
2021-05-01 |
美商普雷西斯精密藥品公司 |
T型鈣離子通道調節劑之調配物及其使用方法
|
BR112022008565A2
(pt)
|
2019-11-04 |
2022-08-09 |
Revolution Medicines Inc |
Composto, composição farmacêutica, conjugado, métodos para tratar câncer e um distúrbio relativo à proteína ras
|
TW202132314A
(zh)
|
2019-11-04 |
2021-09-01 |
美商銳新醫藥公司 |
Ras抑制劑
|
CN115873020A
(zh)
|
2019-11-04 |
2023-03-31 |
锐新医药公司 |
Ras抑制剂
|
CN114980976A
(zh)
|
2019-11-27 |
2022-08-30 |
锐新医药公司 |
共价ras抑制剂及其用途
|
JP2023530351A
(ja)
|
2020-06-18 |
2023-07-14 |
レヴォリューション・メディスンズ,インコーポレイテッド |
Ras阻害剤への獲得耐性を遅延させる、防止する、及び、治療する方法
|
AU2021345111A1
(en)
|
2020-09-15 |
2023-04-06 |
Revolution Medicines, Inc. |
Indole derivatives as Ras inhibitors in the treatment of cancer
|
CA3217393A1
(en)
|
2021-05-05 |
2022-11-10 |
Elena S. Koltun |
Ras inhibitors
|
MX2023013084A
(es)
|
2021-05-05 |
2023-11-17 |
Revolution Medicines Inc |
Inhibidores de ras para el tratamiento del cancer.
|
JP2024516450A
(ja)
|
2021-05-05 |
2024-04-15 |
レボリューション メディシンズ インコーポレイテッド |
共有結合性ras阻害剤及びその使用
|
AR127308A1
(es)
|
2021-10-08 |
2024-01-10 |
Revolution Medicines Inc |
Inhibidores ras
|
WO2023172940A1
(en)
|
2022-03-08 |
2023-09-14 |
Revolution Medicines, Inc. |
Methods for treating immune refractory lung cancer
|
WO2023240263A1
(en)
|
2022-06-10 |
2023-12-14 |
Revolution Medicines, Inc. |
Macrocyclic ras inhibitors
|
WO2024102421A2
(en)
|
2022-11-09 |
2024-05-16 |
Revolution Medicines, Inc. |
Compounds, complexes, and methods for their preparation and of their use
|